Marco Campisi

13PUBLICATIONS
199CO-AUTHORS
Molecular targetsNanomedicineHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 02, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer.

|Feb 18, 2026
miR126-mediated alteration of vascular integrity in Rett syndrome.

Tatsuya Osaki, Zhengpeng Wan, Koji Haratani

|Sep 08, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Elliott J Brea, Simon Baldacci, Neil Savage

|Jan 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor Immunity.

Tetsuo Tani, Haritha Mathsyaraja, Marco Campisi

|Sep 20, 2023
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade.

Saba Tabasum, Dinesh Thapa, Anita Giobbie-Hurder

|Aug 26, 2023
Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells.

Thomas J Gerton, Allen Green, Marco Campisi

Pageof 3

Frequent Collaborators

7 joint publications

David Barbie

5 joint publications

Koji Haratani

5 joint publications

Navin R Mahadevan

5 joint publications

Cloud P Paweletz